SOW
RNAC icon

State of Wyoming’s Cartesian Therapeutics RNAC Stock Holding History

State of Wyoming’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-774
Closed -$26K – 1783
2023
Q2 		$26K Buy
774
+192
+33% +$6.87K 0.01% 1377
2023
Q1 		$24.3K Sell
582
-1,096
-65% -$51.5K 0.01% 1376
2022
Q4 		$56.9K Buy
1,678
+1,239
+282% +$52.7K 0.02% 1024
2022
Q3 		$22K Sell
439
-380
-46% -$20.9K 0.01% 1297
2022
Q2 		$32K Buy
819
+649
+382% +$19.2K 0.02% 1228
2022
Q1 		$6K Sell
170
-753
-82% -$47.1K ﹤0.01% 1650
2021
Q4 		$90K Buy
+923
New +$99.3K 0.04% 718

Other funds holding RNAC

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State of Wyoming's RNAC Position: Q3 2023 in Review

State of Wyoming sold out of Cartesian Therapeutics (RNAC) in Q3 2023, closing a stake of 774 shares — an estimated $26K sold.

State of Wyoming first reported a position in RNAC in Q4 2021 and held it in 7 quarters. The position peaked at $90K in Q4 2021. 87 funds tracked by Wall St. Rank hold RNAC as of Q3 2023.

  • State of Wyoming reported no remaining Cartesian Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Wyoming sold 774 Cartesian Therapeutics shares in Q3 2023, an estimated $26K.
  • State of Wyoming first reported a position in Cartesian Therapeutics in Q4 2021 and held it in 7 quarters.
  • State of Wyoming's Cartesian Therapeutics position peaked at $90K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2023.

Based on State of Wyoming's 13F filing for Q3 2023, filed 14 Nov 2023.